Skip navigation

Chemical Tamoxifen

1–50 of 505 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. 4-hydroxy-N-desmethyltamoxifen cell proliferation 4-hydroxy-N-desmethyltamoxifen results in decreased cell proliferation 1: Homo sapiens Mammary Glands, Human | Cell Line, Tumor
3 genes: AREG | CYP1A1 | MYC
1
2. 4-hydroxy-N-desmethyltamoxifen cell proliferation 4-hydroxy-N-desmethyltamoxifen results in decreased cell proliferation 1: Mus musculus Skin | Cell Line, Tumor
3 genes: AREG | CYP1A1 | MYC
1
3. 4-hydroxy-N-desmethyltamoxifen cell death 4-hydroxy-N-desmethyltamoxifen results in increased cell death 1: Homo sapiens Blood | Cell Line, Tumor   1
4. 4-hydroxytoremifene membrane lipid catabolic process Adenosine Diphosphate | Ascorbic Acid | ferric chloride 4-hydroxytoremifene inhibits the reaction [[Ascorbic Acid co-treated with [Adenosine Diphosphate co-treated with ferric chloride]] results in increased membrane lipid catabolic process] 1: Rattus norvegicus Microsomes, Liver   1
5. 4-hydroxytoremifene membrane lipid catabolic process tert-Butylhydroperoxide 4-hydroxytoremifene inhibits the reaction [tert-Butylhydroperoxide results in increased membrane lipid catabolic process] 1: Rattus norvegicus Microsomes, Liver   1
6. afimoxifene cell proliferation afimoxifene results in decreased cell proliferation 1: Homo sapiens Mammary Glands, Human | Cell Line
48 genes: AKT1 | AR | AREG | BCAR1 | BCL2 | BCL2L1 | BOP1 | CDK1 | CDK9 | COL4A3 | CYP1A1 | DKC1 | EGFR | EPS8 | ERBB2 | FAM83B | GH1 | HDGF | IGF1 | IGFBP4 | IL1A | IRF2 | KLF10 | MAP2K1 | MET | MYB | MYC | NAB2 | NANOG | OGFOD1 | PCNA | PDZK1 | PES1 | PRKDC | PTPN6 | RAF1 | RBBP7 | RHBDF1 | TACC1 | TACSTD2 | TCF7L2 | TOP1 | TP63 | TXNRD1 | VEGFA | VTN | XRCC5 | ZEB1
1
7. afimoxifene cell proliferation afimoxifene results in decreased cell proliferation 1: Homo sapiens Urinary Bladder | Urothelium | Cell Line, Tumor
48 genes: AKT1 | AR | AREG | BCAR1 | BCL2 | BCL2L1 | BOP1 | CDK1 | CDK9 | COL4A3 | CYP1A1 | DKC1 | EGFR | EPS8 | ERBB2 | FAM83B | GH1 | HDGF | IGF1 | IGFBP4 | IL1A | IRF2 | KLF10 | MAP2K1 | MET | MYB | MYC | NAB2 | NANOG | OGFOD1 | PCNA | PDZK1 | PES1 | PRKDC | PTPN6 | RAF1 | RBBP7 | RHBDF1 | TACC1 | TACSTD2 | TCF7L2 | TOP1 | TP63 | TXNRD1 | VEGFA | VTN | XRCC5 | ZEB1
1
8. afimoxifene cell proliferation afimoxifene results in increased cell proliferation 1: Homo sapiens Mammary Glands, Human | Cell Line, Tumor
48 genes: AKT1 | AR | AREG | BCAR1 | BCL2 | BCL2L1 | BOP1 | CDK1 | CDK9 | COL4A3 | CYP1A1 | DKC1 | EGFR | EPS8 | ERBB2 | FAM83B | GH1 | HDGF | IGF1 | IGFBP4 | IL1A | IRF2 | KLF10 | MAP2K1 | MET | MYB | MYC | NAB2 | NANOG | OGFOD1 | PCNA | PDZK1 | PES1 | PRKDC | PTPN6 | RAF1 | RBBP7 | RHBDF1 | TACC1 | TACSTD2 | TCF7L2 | TOP1 | TP63 | TXNRD1 | VEGFA | VTN | XRCC5 | ZEB1
2
9. afimoxifene cell proliferation Sirolimus Sirolimus inhibits the reaction [afimoxifene results in increased cell proliferation] 1: Homo sapiens Mammary Glands, Human | Cell Line, Tumor
48 genes: AKT1 | AR | AREG | BCAR1 | BCL2 | BCL2L1 | BOP1 | CDK1 | CDK9 | COL4A3 | CYP1A1 | DKC1 | EGFR | EPS8 | ERBB2 | FAM83B | GH1 | HDGF | IGF1 | IGFBP4 | IL1A | IRF2 | KLF10 | MAP2K1 | MET | MYB | MYC | NAB2 | NANOG | OGFOD1 | PCNA | PDZK1 | PES1 | PRKDC | PTPN6 | RAF1 | RBBP7 | RHBDF1 | TACC1 | TACSTD2 | TCF7L2 | TOP1 | TP63 | TXNRD1 | VEGFA | VTN | XRCC5 | ZEB1
1
10. afimoxifene cell proliferation Estradiol afimoxifene inhibits the reaction [Estradiol results in increased cell proliferation] 1: Homo sapiens Endometrium | Cell Line, Tumor
48 genes: AKT1 | AR | AREG | BCAR1 | BCL2 | BCL2L1 | BOP1 | CDK1 | CDK9 | COL4A3 | CYP1A1 | DKC1 | EGFR | EPS8 | ERBB2 | FAM83B | GH1 | HDGF | IGF1 | IGFBP4 | IL1A | IRF2 | KLF10 | MAP2K1 | MET | MYB | MYC | NAB2 | NANOG | OGFOD1 | PCNA | PDZK1 | PES1 | PRKDC | PTPN6 | RAF1 | RBBP7 | RHBDF1 | TACC1 | TACSTD2 | TCF7L2 | TOP1 | TP63 | TXNRD1 | VEGFA | VTN | XRCC5 | ZEB1
1
11. afimoxifene membrane lipid catabolic process afimoxifene results in decreased membrane lipid catabolic process 1: Bos Brain 1 gene: CYP1B1 1
12. afimoxifene cell cycle afimoxifene results in decreased cell cycle 1: Homo sapiens Mammary Glands, Human | Cell Line, Tumor
37 genes: AHR | AURKA | BOD1 | CAMK1 | CCNA1 | CCND1 | CCNE1 | CCNE2 | CCNG2 | CDC6 | CDK1 | CDK2 | CDKN1A | CDKN1B | CDKN2B | CDT1 | E2F4 | GPER1 | HNRNPU | MAP3K8 | MAPK1 | MAPK12 | MAPK13 | MAPK3 | MARK4 | NCAPH | PMP22 | PPM1D | PRKCD | RACGAP1 | SIAH2 | SON | STRADA | TACC1 | TIPIN | TP63 | ZWINT
1
13. afimoxifene cell cycle methylselenic acid [methylselenic acid co-treated with afimoxifene] results in decreased cell cycle 1: Homo sapiens Mammary Glands, Human | Cell Line, Tumor
37 genes: AHR | AURKA | BOD1 | CAMK1 | CCNA1 | CCND1 | CCNE1 | CCNE2 | CCNG2 | CDC6 | CDK1 | CDK2 | CDKN1A | CDKN1B | CDKN2B | CDT1 | E2F4 | GPER1 | HNRNPU | MAP3K8 | MAPK1 | MAPK12 | MAPK13 | MAPK3 | MARK4 | NCAPH | PMP22 | PPM1D | PRKCD | RACGAP1 | SIAH2 | SON | STRADA | TACC1 | TIPIN | TP63 | ZWINT
1
14. afimoxifene cell proliferation afimoxifene results in decreased cell proliferation 1: Homo sapiens Mammary Glands, Human | Cell Line, Tumor
48 genes: AKT1 | AR | AREG | BCAR1 | BCL2 | BCL2L1 | BOP1 | CDK1 | CDK9 | COL4A3 | CYP1A1 | DKC1 | EGFR | EPS8 | ERBB2 | FAM83B | GH1 | HDGF | IGF1 | IGFBP4 | IL1A | IRF2 | KLF10 | MAP2K1 | MET | MYB | MYC | NAB2 | NANOG | OGFOD1 | PCNA | PDZK1 | PES1 | PRKDC | PTPN6 | RAF1 | RBBP7 | RHBDF1 | TACC1 | TACSTD2 | TCF7L2 | TOP1 | TP63 | TXNRD1 | VEGFA | VTN | XRCC5 | ZEB1
3
15. afimoxifene cell proliferation Phenolsulfonphthalein Phenolsulfonphthalein promotes the reaction [afimoxifene results in decreased cell proliferation] 1: Homo sapiens Mammary Glands, Human | Cell Line, Tumor
48 genes: AKT1 | AR | AREG | BCAR1 | BCL2 | BCL2L1 | BOP1 | CDK1 | CDK9 | COL4A3 | CYP1A1 | DKC1 | EGFR | EPS8 | ERBB2 | FAM83B | GH1 | HDGF | IGF1 | IGFBP4 | IL1A | IRF2 | KLF10 | MAP2K1 | MET | MYB | MYC | NAB2 | NANOG | OGFOD1 | PCNA | PDZK1 | PES1 | PRKDC | PTPN6 | RAF1 | RBBP7 | RHBDF1 | TACC1 | TACSTD2 | TCF7L2 | TOP1 | TP63 | TXNRD1 | VEGFA | VTN | XRCC5 | ZEB1
1
16. afimoxifene cell proliferation afimoxifene results in decreased cell proliferation 1: Rattus norvegicus Uterus | Myocytes, Smooth Muscle | Cell Line, Tumor
48 genes: AKT1 | AR | AREG | BCAR1 | BCL2 | BCL2L1 | BOP1 | CDK1 | CDK9 | COL4A3 | CYP1A1 | DKC1 | EGFR | EPS8 | ERBB2 | FAM83B | GH1 | HDGF | IGF1 | IGFBP4 | IL1A | IRF2 | KLF10 | MAP2K1 | MET | MYB | MYC | NAB2 | NANOG | OGFOD1 | PCNA | PDZK1 | PES1 | PRKDC | PTPN6 | RAF1 | RBBP7 | RHBDF1 | TACC1 | TACSTD2 | TCF7L2 | TOP1 | TP63 | TXNRD1 | VEGFA | VTN | XRCC5 | ZEB1
1
17. afimoxifene cell death afimoxifene results in increased cell death 1: Homo sapiens Schwann Cells | Cell Line, Tumor
2 genes: CDKN1B | PMP22
1
18. afimoxifene cell proliferation afimoxifene results in decreased cell proliferation 1: Homo sapiens Schwann Cells | Cell Line, Tumor
48 genes: AKT1 | AR | AREG | BCAR1 | BCL2 | BCL2L1 | BOP1 | CDK1 | CDK9 | COL4A3 | CYP1A1 | DKC1 | EGFR | EPS8 | ERBB2 | FAM83B | GH1 | HDGF | IGF1 | IGFBP4 | IL1A | IRF2 | KLF10 | MAP2K1 | MET | MYB | MYC | NAB2 | NANOG | OGFOD1 | PCNA | PDZK1 | PES1 | PRKDC | PTPN6 | RAF1 | RBBP7 | RHBDF1 | TACC1 | TACSTD2 | TCF7L2 | TOP1 | TP63 | TXNRD1 | VEGFA | VTN | XRCC5 | ZEB1
1
19. afimoxifene membrane lipid catabolic process afimoxifene results in decreased membrane lipid catabolic process 1: Rattus norvegicus Heart | Microsomes 1 gene: CYP1B1 1
20. afimoxifene apoptotic process afimoxifene results in increased apoptotic process 1: Homo sapiens Breast | Cell Line, Tumor
41 genes: AHR | AKT1 | AKT2 | BCL2 | BCL2L1 | BIK | CARD6 | CDCA7 | CDK1 | CTSH | DYNLL1 | FAIM2 | GJA1 | GPER1 | IGFBP3 | IL1A | JAK2 | LCK | MAP2K4 | MAP2K6 | MAP2K7 | MAPK1 | MAPK14 | MAPK3 | NME3 | NR4A1 | PAK6 | PLEKHF1 | PPIF | PRKCD | PTPN6 | RAF1 | SERPINB9 | SH3RF1 | SHB | SIAH2 | STK26 | TLR2 | TP53INP1 | TP63 | XBP1
2
21. afimoxifene apoptotic process afimoxifene results in increased apoptotic process 1: Homo sapiens HT29 Cells
41 genes: AHR | AKT1 | AKT2 | BCL2 | BCL2L1 | BIK | CARD6 | CDCA7 | CDK1 | CTSH | DYNLL1 | FAIM2 | GJA1 | GPER1 | IGFBP3 | IL1A | JAK2 | LCK | MAP2K4 | MAP2K6 | MAP2K7 | MAPK1 | MAPK14 | MAPK3 | NME3 | NR4A1 | PAK6 | PLEKHF1 | PPIF | PRKCD | PTPN6 | RAF1 | SERPINB9 | SH3RF1 | SHB | SIAH2 | STK26 | TLR2 | TP53INP1 | TP63 | XBP1
1
22. afimoxifene apoptotic process CSE1L CSE1L protein promotes the reaction [afimoxifene results in increased apoptotic process] 1: Homo sapiens Breast | Cell Line, Tumor
41 genes: AHR | AKT1 | AKT2 | BCL2 | BCL2L1 | BIK | CARD6 | CDCA7 | CDK1 | CTSH | DYNLL1 | FAIM2 | GJA1 | GPER1 | IGFBP3 | IL1A | JAK2 | LCK | MAP2K4 | MAP2K6 | MAP2K7 | MAPK1 | MAPK14 | MAPK3 | NME3 | NR4A1 | PAK6 | PLEKHF1 | PPIF | PRKCD | PTPN6 | RAF1 | SERPINB9 | SH3RF1 | SHB | SIAH2 | STK26 | TLR2 | TP53INP1 | TP63 | XBP1
1
23. afimoxifene apoptotic process CSE1L CSE1L protein promotes the reaction [afimoxifene results in increased apoptotic process] 1: Homo sapiens HT29 Cells
41 genes: AHR | AKT1 | AKT2 | BCL2 | BCL2L1 | BIK | CARD6 | CDCA7 | CDK1 | CTSH | DYNLL1 | FAIM2 | GJA1 | GPER1 | IGFBP3 | IL1A | JAK2 | LCK | MAP2K4 | MAP2K6 | MAP2K7 | MAPK1 | MAPK14 | MAPK3 | NME3 | NR4A1 | PAK6 | PLEKHF1 | PPIF | PRKCD | PTPN6 | RAF1 | SERPINB9 | SH3RF1 | SHB | SIAH2 | STK26 | TLR2 | TP53INP1 | TP63 | XBP1
1
24. afimoxifene cell proliferation Acetaminophen afimoxifene inhibits the reaction [Acetaminophen results in increased cell proliferation] 1: Homo sapiens Breast | Cell Line, Tumor
48 genes: AKT1 | AR | AREG | BCAR1 | BCL2 | BCL2L1 | BOP1 | CDK1 | CDK9 | COL4A3 | CYP1A1 | DKC1 | EGFR | EPS8 | ERBB2 | FAM83B | GH1 | HDGF | IGF1 | IGFBP4 | IL1A | IRF2 | KLF10 | MAP2K1 | MET | MYB | MYC | NAB2 | NANOG | OGFOD1 | PCNA | PDZK1 | PES1 | PRKDC | PTPN6 | RAF1 | RBBP7 | RHBDF1 | TACC1 | TACSTD2 | TCF7L2 | TOP1 | TP63 | TXNRD1 | VEGFA | VTN | XRCC5 | ZEB1
1
25. afimoxifene cell proliferation Estradiol afimoxifene inhibits the reaction [Estradiol results in increased cell proliferation] 1: Homo sapiens MCF-7 Cells
48 genes: AKT1 | AR | AREG | BCAR1 | BCL2 | BCL2L1 | BOP1 | CDK1 | CDK9 | COL4A3 | CYP1A1 | DKC1 | EGFR | EPS8 | ERBB2 | FAM83B | GH1 | HDGF | IGF1 | IGFBP4 | IL1A | IRF2 | KLF10 | MAP2K1 | MET | MYB | MYC | NAB2 | NANOG | OGFOD1 | PCNA | PDZK1 | PES1 | PRKDC | PTPN6 | RAF1 | RBBP7 | RHBDF1 | TACC1 | TACSTD2 | TCF7L2 | TOP1 | TP63 | TXNRD1 | VEGFA | VTN | XRCC5 | ZEB1
2
26. afimoxifene long-term synaptic depression bisphenol A afimoxifene inhibits the reaction [bisphenol A results in increased long-term synaptic depression] 1: Rattus norvegicus Hippocampus
2 genes: AKT1 | DRD1
1
27. afimoxifene cell proliferation afimoxifene results in decreased cell proliferation 1: Homo sapiens MCF-7 Cells
48 genes: AKT1 | AR | AREG | BCAR1 | BCL2 | BCL2L1 | BOP1 | CDK1 | CDK9 | COL4A3 | CYP1A1 | DKC1 | EGFR | EPS8 | ERBB2 | FAM83B | GH1 | HDGF | IGF1 | IGFBP4 | IL1A | IRF2 | KLF10 | MAP2K1 | MET | MYB | MYC | NAB2 | NANOG | OGFOD1 | PCNA | PDZK1 | PES1 | PRKDC | PTPN6 | RAF1 | RBBP7 | RHBDF1 | TACC1 | TACSTD2 | TCF7L2 | TOP1 | TP63 | TXNRD1 | VEGFA | VTN | XRCC5 | ZEB1
1
28. afimoxifene cell proliferation afimoxifene results in decreased cell proliferation 1: Homo sapiens Breast | Cell Line, Tumor
48 genes: AKT1 | AR | AREG | BCAR1 | BCL2 | BCL2L1 | BOP1 | CDK1 | CDK9 | COL4A3 | CYP1A1 | DKC1 | EGFR | EPS8 | ERBB2 | FAM83B | GH1 | HDGF | IGF1 | IGFBP4 | IL1A | IRF2 | KLF10 | MAP2K1 | MET | MYB | MYC | NAB2 | NANOG | OGFOD1 | PCNA | PDZK1 | PES1 | PRKDC | PTPN6 | RAF1 | RBBP7 | RHBDF1 | TACC1 | TACSTD2 | TCF7L2 | TOP1 | TP63 | TXNRD1 | VEGFA | VTN | XRCC5 | ZEB1
1
29. afimoxifene cell proliferation afimoxifene results in decreased cell proliferation 1: Homo sapiens Ovary | Cell Line, Tumor
48 genes: AKT1 | AR | AREG | BCAR1 | BCL2 | BCL2L1 | BOP1 | CDK1 | CDK9 | COL4A3 | CYP1A1 | DKC1 | EGFR | EPS8 | ERBB2 | FAM83B | GH1 | HDGF | IGF1 | IGFBP4 | IL1A | IRF2 | KLF10 | MAP2K1 | MET | MYB | MYC | NAB2 | NANOG | OGFOD1 | PCNA | PDZK1 | PES1 | PRKDC | PTPN6 | RAF1 | RBBP7 | RHBDF1 | TACC1 | TACSTD2 | TCF7L2 | TOP1 | TP63 | TXNRD1 | VEGFA | VTN | XRCC5 | ZEB1
1
30. afimoxifene cell proliferation afimoxifene results in decreased cell proliferation 1: Homo sapiens Prostate | Cell Line, Tumor
48 genes: AKT1 | AR | AREG | BCAR1 | BCL2 | BCL2L1 | BOP1 | CDK1 | CDK9 | COL4A3 | CYP1A1 | DKC1 | EGFR | EPS8 | ERBB2 | FAM83B | GH1 | HDGF | IGF1 | IGFBP4 | IL1A | IRF2 | KLF10 | MAP2K1 | MET | MYB | MYC | NAB2 | NANOG | OGFOD1 | PCNA | PDZK1 | PES1 | PRKDC | PTPN6 | RAF1 | RBBP7 | RHBDF1 | TACC1 | TACSTD2 | TCF7L2 | TOP1 | TP63 | TXNRD1 | VEGFA | VTN | XRCC5 | ZEB1
1
31. afimoxifene apoptotic process 4-hydroxycyclophosphamide afimoxifene inhibits the reaction [4-hydroxycyclophosphamide results in increased apoptotic process] 1: Rattus norvegicus Ovarian Follicle
41 genes: AHR | AKT1 | AKT2 | BCL2 | BCL2L1 | BIK | CARD6 | CDCA7 | CDK1 | CTSH | DYNLL1 | FAIM2 | GJA1 | GPER1 | IGFBP3 | IL1A | JAK2 | LCK | MAP2K4 | MAP2K6 | MAP2K7 | MAPK1 | MAPK14 | MAPK3 | NME3 | NR4A1 | PAK6 | PLEKHF1 | PPIF | PRKCD | PTPN6 | RAF1 | SERPINB9 | SH3RF1 | SHB | SIAH2 | STK26 | TLR2 | TP53INP1 | TP63 | XBP1
1
32. afimoxifene neuron projection development ESR1 | NGF afimoxifene promotes the reaction [[NGF protein co-treated with ESR1 protein] results in increased neuron projection development] 1: Rattus norvegicus PC12 Cells
9 genes: AREG | CD24 | CDH1 | GRM4 | HMGB1 | IGF1R | LYN | MAPK8 | MAPK9
1
33. afimoxifene positive regulation of intracellular estrogen receptor signaling pathway Estradiol afimoxifene inhibits the reaction [Estradiol results in increased positive regulation of intracellular estrogen receptor signaling pathway] 1: Homo sapiens Ovary | Cell Line, Tumor 1 gene: AR 1
34. afimoxifene positive regulation of cell proliferation pterostilbene | Resveratrol [Resveratrol co-treated with pterostilbene] promotes the reaction [afimoxifene results in decreased positive regulation of cell proliferation] 1: Homo sapiens Mammary Glands, Human | Cell Line, Tumor
57 genes: AKT1 | AKT2 | AR | AREG | ARNT2 | BCL2 | BCL2L1 | CCND1 | CDK2 | CDKN1B | CNBP | CTSH | CXCL12 | DKC1 | EGF | EGFR | EPHA1 | ERBB2 | FLT1 | FN1 | GAB2 | GPER1 | HMGB1 | ID3 | IGF1 | IGF1R | IL7R | JAK2 | JUN | LYN | MAPK1 | MARK4 | MIR21 | MYB | MYC | NANOG | NCOR1 | NOLC1 | NPM1 | PGR | PRKAA1 | PRKCZ | PTHLH | PTPN6 | RARA | SOX9 | SPHK1 | STAT1 | TBX3 | TGFB3 | TIPIN | TSC22D1 | TSPYL5 | VEGFA | VIPR1 | XBP1 | ZNF703
1
35. afimoxifene positive regulation of cell proliferation afimoxifene results in decreased positive regulation of cell proliferation 1: Homo sapiens MCF-7 Cells
57 genes: AKT1 | AKT2 | AR | AREG | ARNT2 | BCL2 | BCL2L1 | CCND1 | CDK2 | CDKN1B | CNBP | CTSH | CXCL12 | DKC1 | EGF | EGFR | EPHA1 | ERBB2 | FLT1 | FN1 | GAB2 | GPER1 | HMGB1 | ID3 | IGF1 | IGF1R | IL7R | JAK2 | JUN | LYN | MAPK1 | MARK4 | MIR21 | MYB | MYC | NANOG | NCOR1 | NOLC1 | NPM1 | PGR | PRKAA1 | PRKCZ | PTHLH | PTPN6 | RARA | SOX9 | SPHK1 | STAT1 | TBX3 | TGFB3 | TIPIN | TSC22D1 | TSPYL5 | VEGFA | VIPR1 | XBP1 | ZNF703
1
36. afimoxifene proline biosynthetic process Estradiol afimoxifene inhibits the reaction [Estradiol results in increased proline biosynthetic process] 1: Homo sapiens MCF-7 Cells   1
37. afimoxifene proline biosynthetic process bisphenol A afimoxifene inhibits the reaction [bisphenol A results in increased proline biosynthetic process] 1: Homo sapiens MCF-7 Cells   1
38. afimoxifene positive regulation of intracellular estrogen receptor signaling pathway Estradiol afimoxifene inhibits the reaction [Estradiol results in increased positive regulation of intracellular estrogen receptor signaling pathway] 1: Homo sapiens   1 gene: AR 1
39. afimoxifene negative regulation of neuronal action potential afimoxifene results in increased negative regulation of neuronal action potential 1: Pelophylax nigromaculatus Sciatic Nerve   1
40. afimoxifene neuronal action potential propagation afimoxifene results in decreased neuronal action potential propagation 1: Pelophylax nigromaculatus Sciatic Nerve 1 gene: PMP22 1
41. afimoxifene positive regulation of nuclear receptor transcription coactivator activity ESR1 | Estradiol afimoxifene inhibits the reaction [[Estradiol co-treated with ESR1 protein] results in increased positive regulation of nuclear receptor transcription coactivator activity] 1: Homo sapiens Uterus   1
42. afimoxifene negative regulation of cell proliferation afimoxifene results in increased negative regulation of cell proliferation 1: Homo sapiens Mammary Glands, Human | Cell Line, Tumor
46 genes: AR | AXUD1 | BCL2 | BDKRB2 | BMP7 | BTG1 | CDC6 | CDKN1A | CDKN1B | CDKN2B | COL4A3 | CYP1B1 | ESR2 | FRK | GJA1 | GPER1 | GRM4 | IGF1 | IGFBP3 | IL1A | JAK2 | JUN | KLF10 | LYN | MAP2K1 | MIR21 | NPM1 | PMP22 | PPM1D | PTGES | PTHLH | PTPN6 | RAF1 | RARA | RXRA | SH3BP4 | SLIT2 | SOX9 | TFAP2A | TFAP4 | TFF1 | TGFB3 | TLR2 | TP53INP1 | VDR | ZEB1
1
43. afimoxifene negative regulation of cell migration afimoxifene results in increased negative regulation of cell migration 1: Homo sapiens Mammary Glands, Human | Cell Line, Tumor
9 genes: BCL2 | CDH1 | CYP1B1 | DRD1 | EPHA1 | MIR21 | SLIT2 | STK26 | TP53INP1
1
44. afimoxifene positive regulation of p38MAPK cascade afimoxifene results in increased positive regulation of p38MAPK cascade 1: Homo sapiens Mammary Glands, Human | Cell Line, Tumor
2 genes: MET | VEGFA
1
45. afimoxifene cell proliferation afimoxifene results in increased cell proliferation 1: Homo sapiens MCF-7 Cells
48 genes: AKT1 | AR | AREG | BCAR1 | BCL2 | BCL2L1 | BOP1 | CDK1 | CDK9 | COL4A3 | CYP1A1 | DKC1 | EGFR | EPS8 | ERBB2 | FAM83B | GH1 | HDGF | IGF1 | IGFBP4 | IL1A | IRF2 | KLF10 | MAP2K1 | MET | MYB | MYC | NAB2 | NANOG | OGFOD1 | PCNA | PDZK1 | PES1 | PRKDC | PTPN6 | RAF1 | RBBP7 | RHBDF1 | TACC1 | TACSTD2 | TCF7L2 | TOP1 | TP63 | TXNRD1 | VEGFA | VTN | XRCC5 | ZEB1
1
46. GSK5182 fibrinogen complex arachidonyl-2-chloroethylamide GSK5182 inhibits the reaction [arachidonyl-2-chloroethylamide results in increased fibrinogen complex] 1: Mus musculus Liver | Cell Line
3 genes: FGA | FGB | FGG
1
47. GSK5182 fibrinogen complex Dietary Fats GSK5182 inhibits the reaction [Dietary Fats results in increased fibrinogen complex] 1: Mus musculus Liver
3 genes: FGA | FGB | FGG
1
48. hydroxytamoxifen low-density lipoprotein particle clearance hydroxytamoxifen results in decreased low-density lipoprotein particle clearance 1: Homo sapiens Macrophages | Cell Line 1 gene: CD36 1
49. hydroxytamoxifen low-density lipoprotein particle clearance malondialdehyde-low density lipoprotein, human [hydroxytamoxifen results in decreased low-density lipoprotein particle clearance] which results in decreased uptake of malondialdehyde-low density lipoprotein, human 1: Homo sapiens Macrophages | Cell Line 1 gene: CD36 1
50. hydroxytamoxifen positive regulation of protein import into nucleus Rosiglitazone hydroxytamoxifen inhibits the reaction [Rosiglitazone results in increased positive regulation of protein import into nucleus] 1: Homo sapiens Macrophages | Cell Line   1
1–50 of 505 results.